Jing Li is a Principal Scientist and Group Leader at Genentech, where they focus on developing new technologies for multi-specific drug discovery. Their current research includes targeted protein degradation on the cell surface and innovative methods for drug delivery. Jing’s previous roles include serving as a Postdoctoral Scientist at Amgen and as a Postdoctoral Fellow at the California Institute of Technology, as well as a Scientist at Genentech. They are pursuing a Doctor's Degree at the International Max Planck Research School for Molecular Life Sciences and a Ph.D. at Technische Universität München.
This person is not in the org chart
This person is not in any teams
This person is not in any offices